CFO Aradhana Sarin noted that full-year total revenue ... and accelerating launches in emerging markets. AstraZeneca’s Q4 2024 results underscore strong business momentum, driven by robust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback